Navigation Links
VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis
Date:7/21/2008

Detailed lipid profile helps clinicians identify risk in patients, including non-diabetics, despite normal LDL levels and statin therapy

BIRMINGHAM, Ala., July 21 /PRNewswire/ -- Using the VAP Cholesterol Test from Atherotech, researchers have identified a link between adiponectin and heart disease progression. The information could help physicians trying to pinpoint the most effective cholesterol and heart disease risk-lowering treatments in at-risk patients.

The association between low adiponectin levels, abnormal lipids, and increased coronary atherosclerosis was confirmed using the expanded cholesterol profiling capabilities of the VAP Test plus an adiponectin assay as part of an Intravascular Ultrasound (IVUS) substudy of the Diabetes Genome Project.

The single-center, prospective gene and biomarker banking registry was designed to collect extensive clinical and anatomic information on patients undergoing coronary angiography. For the substudy, fasting blood samples were collected from 185 patients undergoing coronary angiography and IVUS. Lipoprotein subclasses were measured by the VAP Test; adiponectin was measured using an immunoassay from R&D Systems.

Results of the study, published in the May issue of Diabetes Care, showed that low adiponectin levels are associated with small dense LDL cholesterol, increased plaque volume as measured by lipid-rich plaques, and a higher prevalence of IVUS-derived thickening of the inner-lining of blood vessels in non-diabetic patients. Seventy five percent of the patients were taking cholesterol lowering statins and had LDL cholesterol levels well below the required cut-off for study inclusion of 100mg/dL as well as normal HDL cholesterol levels and normal triglycerides.

"The VAP Test allowed us to define the relationship between adiponectin and circulating lipids," said Principal Investigator Steve Marso, M.D. "Had we not characterized the LDL subparticles we would not have fou
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
2. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
3. Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
4. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
5. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
6. People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels
7. Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
8. Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol
9. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
10. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
11. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),a...vering,developingandcommercializingnoveldrugstotre...scalyearendedSeptember30,2009.AtSeptember30,2009Ph...hortterminvestments. ,, PipelineUpdateand2009H..., InlateNovember2009,anindependentDataMonitorin...
(Date:11/25/2009)...,Nov.25/PRNewswire/-- FromNovember16-18,Phonak,the...esentedthesecondeditionoftheHearingCareforAdultsCo...tion.Theconferencebroughttogetherleadingexpertsina...inicianswhoworkeverydaywitholderpeoplewithhearingl...latestresearchandtrendsinhearingcareforolderpeople...
(Date:11/25/2009)...ewswire/--TheFDAgrantedtraditionalapprovalforINTEL...setranscriptaseinhibitor(NNRTI).INTELENCEistheonly...encedadultswhoareexperiencingvirologicfailurewithH...l(ARV)agents.Thetraditionalapprovalisbasedon48-wee...TELENCEiscurrentlymarketedintheU.S.byTibotecTherap...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 1Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3
...one Systems Incorporated,(Nasdaq: IMCL ) and Bris...nced,that the U.S. Food and Drug Administration (F...ximab) product labeling to include overall surviva...r inhibitor,(EGFR)-expressing metastatic colorecta...notecan- and oxaliplatin-based regimens. The appr...
...cond Cerimon Product Candidate to Enter Clinical ...SAN FRANCISCO, Oct. 2 Cerimon Pharmaceuticals,Inc...ical study of a novel,diclofenac sodium patch, the...e safety, tolerability, and systemic pharmacokinet...odium, a non-steroidal anti-inflammatory,drug (NSA...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3
(Date:11/25/2009)...,, LOSANGELES,Nov.25/PRNewswire-USNewswire/--Th...tionstodetermineexecutiveleadershipfor2010. ,, ...ithspecialtiesinpublicpolicy,law,finance,governmen...hip.TheBoardalsocomesfromawiderangeofpersonalbackg...men,somelivingwithHIVthemselves,andrepresentingmul...
(Date:11/25/2009)... A fortuitous discovery that grew out of a collab...d potentially offer hope to the nearly 10 million ...ase. , Also known as hardening of the arteri...on circulatory problem in which narrowed arteries ...onsidered a red flag for vascular disease, heart a...
(Date:11/25/2009)...tigue, forgetfulness could lead mothers to overloo..., Nov. 25 (HealthDay News) -- A mother,s depressio...have found. , Their six-month study of 262 blac...hose mothers had more depressive symptoms had more...rs with fewer depressive symptoms had less frequen...
(Date:11/25/2009)...,, LittleImprovementShownforthe4thStraightYea...-- Today,LungCancerAlliance-Georgia(LCA-GA)issued...nassessmentofprogressbeingmadeagainstthislethaldis...erAlliance(LCA),theonlynationalorganizationdedicat...ivingwithoratriskforlungcancer. ,, (Logo: http:...
(Date:11/25/2009)...udy found puffs of air on flesh that mimicked part... , WEDNESDAY, Nov. 25 (HealthDay News) -- People...h their skin, new research shows. , In fact, se...es of speech actually helped people decipher sound...have never been able to show whether we could use ...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...ers' access to a high-profile detainee at Guantana...gation //techniques "national security secrets" wh...", the Washington Post reported Saturday. The U..., the Post reported. A lawyer at a firm that re...
...nosed on November 3, 1906. One hundred years after...ng on neuroscience, immunology and vaccine researc...D develops and progresses. Researchers at the Yerk...in disorder. About 20 million Americans are curren...
...mune system to control HIV infection appears to de...ystem molecules// called HLA Class I that have bee...protein those molecules display to the T lymphocyt...achusetts General Hospital (PARC/MGH) report that ...
...een simmering in the trans-fat controversy for qui...r sticky ally- the hydrogenated// vegetable oils! ... KFC, Marks & Spencer, Asda, Sainsbury’s and Tesco... to bring in a law that would entail manufacturers...
...patients who behave in an unbecoming manner, and w...e by an NHS hospital to punish patients// that dis...avior. The Royal Bolton hospital in Greater...ts of violence in hospitals where security staff h...
...agazine for men with a tall worldwide readership o... survey that queried almost 40,000 men// from 43 c... habits. An exclusive feature titled "World's Best...indulged in one night escapades. All the same, Ind...
Other Medicine News:Health News:Genes determine the capacity to fight HIV in early stages 2Health News:Genes determine the capacity to fight HIV in early stages 3
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: